Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

Value-added reporting of antinuclear antibody testing by automated indirect immunofluorescence analysis.

Schouwers S, Bonnet M, Verschueren P, Westhovens R, Blockmans D, Mariën G, Bossuyt X.

Clin Chem Lab Med. 2014 Apr;52(4):547-51. doi: 10.1515/cclm-2013-0610.

PMID:
24225130
2.

Detection of antinuclear antibodies by indirect immunofluorescence and by solid phase assay.

Op De Beeck K, Vermeersch P, Verschueren P, Westhovens R, Mariën G, Blockmans D, Bossuyt X.

Autoimmun Rev. 2011 Oct;10(12):801-8. doi: 10.1016/j.autrev.2011.06.005. Epub 2011 Jun 30. Review.

PMID:
21741497
3.

Detection of antinuclear antibodies by automated indirect immunofluorescence analysis.

Bossuyt X, Cooreman S, De Baere H, Verschueren P, Westhovens R, Blockmans D, Mariën G.

Clin Chim Acta. 2013 Jan 16;415:101-6. doi: 10.1016/j.cca.2012.09.021. Epub 2012 Sep 28.

PMID:
23026234
4.

[The automated analysis of anti-nuclear antibodies using technique of indirect reaction of immunofluorescence with application of HEP-2-cells].

Aleksandrova EN, Verijnikova JG, Novikov AA, Baranov AA, Abaitova NE, Lapkina NA, Roggenbuk D, Nasonov EL.

Klin Lab Diagn. 2015 Mar;60(3):30-5. Russian.

PMID:
26031162
5.

Automated antinuclear immunofluorescence antibody screening: a comparative study of six computer-aided diagnostic systems.

Bizzaro N, Antico A, Platzgummer S, Tonutti E, Bassetti D, Pesente F, Tozzoli R, Tampoia M, Villalta D; Study Group on Autoimmune Diseases of the Italian Society of Laboratory Medicine, Italy.

Autoimmun Rev. 2014 Mar;13(3):292-8. doi: 10.1016/j.autrev.2013.10.015. Epub 2013 Nov 9. Review.

PMID:
24220268
6.

Added value of indirect immunofluorescence intensity of automated antinuclear antibody testing in a secondary hospital setting.

Oyaert M, Bossuyt X, Ravelingien I, Van Hoovels L.

Clin Chem Lab Med. 2016 Feb;54(2):e63-6. doi: 10.1515/cclm-2015-0887. No abstract available.

PMID:
26562037
7.

Original approach for automated quantification of antinuclear autoantibodies by indirect immunofluorescence.

Bertin D, Jourde-Chiche N, Bongrand P, Bardin N.

Clin Dev Immunol. 2013;2013:182172. doi: 10.1155/2013/182172. Epub 2013 Dec 18.

8.

Antinuclear antibody detection by automated multiplex immunoassay in untreated patients at the time of diagnosis.

Op De Beéck K, Vermeersch P, Verschueren P, Westhovens R, Mariën G, Blockmans D, Bossuyt X.

Autoimmun Rev. 2012 Dec;12(2):137-43. doi: 10.1016/j.autrev.2012.02.013. Epub 2012 Feb 23. Review.

PMID:
22387973
9.

Automated indirect immunofluorescence antinuclear antibody analysis is a standardized alternative for visual microscope interpretation.

Bonroy C, Verfaillie C, Smith V, Persijn L, De Witte E, De Keyser F, Devreese K.

Clin Chem Lab Med. 2013 Sep;51(9):1771-9. doi: 10.1515/cclm-2013-0016. Erratum in: Clin Chem Lab Med. 2014 Nov;52(11):1677.

PMID:
23612554
10.

Second generation analysis of antinuclear antibody (ANA) by combination of screening and confirmatory testing.

Scholz J, Grossmann K, Knütter I, Hiemann R, Sowa M, Röber N, Rödiger S, Schierack P, Reinhold D, Bogdanos DP, Meroni PL, Radice A, Conrad K, Roggenbuck D.

Clin Chem Lab Med. 2015 Nov;53(12):1991-2002. doi: 10.1515/cclm-2015-0083.

11.

Interpretation of ANA indirect immunofluorescence test outside the darkroom using NOVA view compared to manual microscopy.

Copple SS, Jaskowski TD, Giles R, Hill HR.

J Immunol Res. 2014;2014:149316. doi: 10.1155/2014/149316. Epub 2014 Feb 24.

12.

Impact of the routine implementation of automated indirect immunofluorescence antinuclear antibody analysis: 1 year of experience.

Mulliez SM, Maenhout TM, Bonroy C.

Clin Chem Lab Med. 2016 Jul 1;54(7):e183-6. doi: 10.1515/cclm-2015-0900. No abstract available.

PMID:
26562038
13.

Reconstructing a 3-dimensional image of the results of antinuclear antibody testing by indirect immunofluorescence.

Murai R, Yamada K, Tanaka M, Kuribayashi K, Kobayashi D, Tsuji N, Watanabe N.

J Immunol Methods. 2013 Jan 31;387(1-2):312-6. doi: 10.1016/j.jim.2012.10.004. Epub 2012 Oct 13.

PMID:
23073364
14.

A novel automated indirect immunofluorescence autoantibody evaluation.

Kivity S, Gilburd B, Agmon-Levin N, Carrasco MG, Tzafrir Y, Sofer Y, Mandel M, Buttner T, Roggenbuck D, Matucci-Cerinic M, Danko K, Hoyos ML, Shoenfeld Y.

Clin Rheumatol. 2012 Mar;31(3):503-9. doi: 10.1007/s10067-011-1884-1. Epub 2011 Nov 5.

PMID:
22057233
15.

Diagnostic profile on the IFA 40: HEp-20-10 - an immunofluorescence test for reliable antinuclear antibody screening.

Rohwäder E, Locke M, Fraune J, Fechner K.

Expert Rev Mol Diagn. 2015 Apr;15(4):451-62. doi: 10.1586/14737159.2015.993612. Epub 2014 Dec 20.

PMID:
25530004
16.
17.

Autoantibodies Against DFS70/LEDGF Exclusion Markers for Systemic Autoimmune Rheumatic Diseases (SARD).

Seelig CA, Bauer O, Seelig HP.

Clin Lab. 2016;62(4):499-517. Review.

PMID:
27215068
18.

Antinuclear antibody test.

O'Sullivan M, McLean-Tooke A, Loh RK.

Aust Fam Physician. 2013 Oct;42(10):718-21.

19.

Detection of anti-nuclear antibodies by indirect immunofluorescence on HEp-2 cells: setting the appropriate screening dilution for the diagnosis of autoimmune rheumatic diseases.

Brito Fde A, Santos SM, Ferreira GA, Pedrosa W, Gradisse J, Costa LC, Neves SP.

Rev Bras Reumatol. 2014 Jan-Feb;54(1):13-20. English, Portuguese.

20.

ICARE improves antinuclear antibody detection by overcoming the barriers preventing accreditation.

Bertin D, Mouhajir Y, Bongrand P, Bardin N.

Clin Chim Acta. 2016 Feb 15;454:57-61. doi: 10.1016/j.cca.2015.12.034. Epub 2015 Dec 30.

PMID:
26742604

Supplemental Content

Support Center